Marketa Nezvedova

Marketa Nezvedova

Auto-generated profile, based on publicly available information

Marketa Nezvedova

Department of Experimental Biology and RECETOX, Faculty of Science, Masaryk University, Kamenice 5, Brno 625 00, Czech Republic

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
MNMarkéta Nezvedová
Markéta Nezvedová
VPVolodymyr Porokh
Volodymyr Porokh
TBTami Bočková
Tami Bočková
VPVáclav Pustka
Václav Pustka
DKDrahomíra Kyjovská
Drahomíra Kyjovská
ZHZuzana Holubcová
Zuzana Holubcová
Soluble proteins present in spent culture media (SCM) have been proposed as potential indicators of embryo viability. However, results across studies remain inconsistent, and the identity of reliable protein biomarkers is still unclear. To evaluate the potential of secretome profiling for non-invasive embryo assessment, we applied state-of-the-art mass spectrometry to analyze the protein composition of SCM from individual successful and unsuccessful human embryo cultures, alongside corresponding controls cultured under identical conditions. Surprisingly, both untargeted (nanoLC-TIMS-TOF-MS/MS) and targeted (UHPLC-QqQ-MS/MS) proteomic analyses consistently detected multiple human proteins in unconditioned media, indicating that these signals are not of embryonic origin. Undeclared proteins were also identified in media sampled before their first use, with considerable variability observed across production batches. Supplementation experiments demonstrated that this variability originates from the addition of plasma-derived human serum albumin, which introduces a range of contaminating proteins. In contrast, recombinant albumin did not contribute detectable serum proteins. These findings indicate that the protein background in commercial IVF media is an overlooked variable, not only compromising the reproducibility and interpretation of secretome analyses in research, but also contributing to unstandardized culture conditions in clinical IVF practice. While this study evaluated 13 production lots of monophasic media from two different manufacturers, the results underscore a broader need for transparency and standardization in IVF media composition. The adoption of fully chemically defined IVF media, free from purified serum components, would support more consistent embryo culture conditions and advance the discovery of biomarkers in SCM.

1 May 2026 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
ALAnthony Legrand
Anthony Legrand
KCKaterina Amruz Cerna
Katerina Amruz Cerna
Sérgio M. MarquesSérgio M. Marques
Sérgio M. Marques
NVNaina Verma
Naina Verma
JKJakub Kopko
Jakub Kopko
ZPZbynek Prokop
Zbynek Prokop
Apolipoprotein E4 (ApoE4) is a major genetic risk factor in many neurodegenerative diseases, yet effective therapeutic strategies targeting its associated pathologies remain unresolved. The aggregation of ApoE4, a key pathological feature, is modulated by tramiprosate and its metabolite 3-sulfopropanoic acid. In this study, we provide mechanistic insights into how taurine, a close chemical analogue of tramiprosate, interacts with ApoE4 and may similarly modulate its aggregation behavior. Using an integrated approach, which included molecular dynamics simulations, static light scattering, mass spectrometry, and cerebral organoid models, we investigated the effects of taurine on ApoE4 aggregation. Our results indicate that taurine effectively prevents ApoE4 aggregation and exerts a partial disaggregating effect on pre-formed aggregates. Notably, taurine modulates molecular and cellular features associated with the ApoE4 isoform, shifting them toward patterns observed in the more benign ApoE3 isoform. These observations are consistent with effects similar to those reported for tramiprosate and 3-sulfopropanoic acid and suggest that taurine influences ApoE4-related molecular mechanisms, particularly in the context of the high-risk ApoE4/E4 genotype.